Saltanat B. Baikoshkarova
Research Subjects
Saltanat B. Baikoshkarova has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Almagul Kurmanova
Faculty of Medicine and Healthcare, Al-Farabi Kazakh National University, 71 Al-Farabi Ave., 050040 Almaty, Kazakhstan
1 shared publication - Balzira Bishekova
Asfendiyarov Kazakh National Medical University
1 shared publication - Gaini Anartayeva
Al-Farabi Kazakh National University, Kazakhstan
1 shared publication - Nagima M. Mamedalieva
Department of Obstetrics and Gynecology, Scientific Center for Obstetrics, Gynecology and Perinatology, Asfendiyarov Kazakh National Medical University, Almaty, KAZAKHSTAN
1 shared publication - Saule Issenova
Department of Obstetrics and Gynecology, Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 20 December 2021
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (sup1) , 26-30
The effectiveness of micronized progesterone in the complex therapy of ‘thin endometry’ syndrome
The article presents the results of examination of 30 patients with a history of miscarriage and ‘thin’ endometrium in comparison with 20 patients without reproductive loss and the presence of normal endometrial thickness. The dynamics of intracellular production of γ-INF, IL-1 and IL-10 by cytotoxic endometrial lymphocytes was studied by flow cytometry. It was found that before treatment in patients with miscarriage and thin endometrium syndrome there was a significant (12-fold) decrease in the level of CD8+ cytotoxic/suppressor lymphocytes (p < .01), a 2.8-fold decrease in the level of CD56+ cells, and also a sharp inhibition of the level of intracellular production of cytokines - γ-INF (8 times), IL-1 (11 times) and IL-10 (15 times). Against the background of complex therapy, including the elimination of pathogenic pathogens, antiplatelet therapy, intrauterine ultrasound cavitation and personalized hormonal therapy using intravaginal micronized progesterone (Luteina), an increase of endometrial thickness was observed: M-echo from 5.9 ± 0.1 to 10.2 ± 0.2 mm; the frequency of visualization of uterine vessels increased to 80–100%; in the spiral arteries, the pulsation index significantly decreased—PI (1.43 ± 0.04 vs. 0.79 ± 0.06), resistance index RI (0.96 ± 0.05 vs. 0.54 ± 0.04), systolic–diastolic ratio S/D in the uterine (4.5 ± 0.04 vs. 2.3 ± 0.05) and arcuate arteries (3.67 ± 0.04 vs. 2.41 ± 0.02); and there was also a positive dynamics of intracellular cytokine production with a significant (p < .05) increase in the level of IL-1 and IL-10, as well as the level of γ-IFN CD56+ by endometrial lymphocytes.
- 20 December 2021
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (sup1) , 26-30
Open AccessThe effectiveness of micronized progesterone in the complex therapy of ‘thin endometry’ syndrome
The article presents the results of examination of 30 patients with a history of miscarriage and ‘thin’ endometrium in comparison with 20 patients without reproductive loss and the presence of normal endometrial thickness. The dynamics of intracellular production of γ-INF, IL-1 and IL-10 by cytotoxic endometrial lymphocytes was studied by flow cytometry. It was found that before treatment in patients with miscarriage and thin endometrium syndrome there was a significant (12-fold) decrease in the level of CD8+ cytotoxic/suppressor lymphocytes (p < .01), a 2.8-fold decrease in the level of CD56+ cells, and also a sharp inhibition of the level of intracellular production of cytokines - γ-INF (8 times), IL-1 (11 times) and IL-10 (15 times). Against the background of complex therapy, including the elimination of pathogenic pathogens, antiplatelet therapy, intrauterine ultrasound cavitation and personalized hormonal therapy using intravaginal micronized progesterone (Luteina), an increase of endometrial thickness was observed: M-echo from 5.9 ± 0.1 to 10.2 ± 0.2 mm; the frequency of visualization of uterine vessels increased to 80–100%; in the spiral arteries, the pulsation index significantly decreased—PI (1.43 ± 0.04 vs. 0.79 ± 0.06), resistance index RI (0.96 ± 0.05 vs. 0.54 ± 0.04), systolic–diastolic ratio S/D in the uterine (4.5 ± 0.04 vs. 2.3 ± 0.05) and arcuate arteries (3.67 ± 0.04 vs. 2.41 ± 0.02); and there was also a positive dynamics of intracellular cytokine production with a significant (p < .05) increase in the level of IL-1 and IL-10, as well as the level of γ-IFN CD56+ by endometrial lymphocytes.